Inflammation and Coagulation: Linked Processes Potentially Regulated Through a Common Pathway Mediated by Protein C

• References

• 1 Mann KG, Nesheim ME, Church WR, Haley P, Krishnaswamy S. Surface-dependent reactions of the vitamin K-dependent enzyme complexes. Blood 1990; 76: 1-16
• 2 Taylor Jr FB. Studies of the natural history and mechanism of the primate (baboon) response to E. coli. . In: Immunopharmacology and pathophysiology of lipopolysaccharides, Bacterial Endotoxic Lipopolysaccharides Series. ( DC Morrison, JL Ryan. eds. ), CRC Press: Vol. 2, in press
• 3 Hinshaw LB, Chang ACK, Beller-Todd BK, Archer LT, Taylor Jr FB. Extracorporeal perfusion without exogenous anticoagulation: Its protective role in endotoxin shock. Circ. Shock 1982; 9: 281-295
• 4 Fletcher JR, McKee AE, Herman CM. Membrane oxygenation in baboons without anticoagulants. J. Surg. Res. 1977; 22: 273-280
• 5 Esmon CT, Owen WG. Identification of an endothelial cell cofactor for thrombin-catalyzed activation of protein C. Proc. Natl. Acad. Sci. (USA) 1981; 78: 2249-2252
• 6 Esmon CT. The roles of protein C and thrombomodulin in the regulation of blood coagulation. J. Biol. Chem. 1989; 264: 4743-4746
• 7 Comp PC, Jacocks RM, Ferrell GL, Esmon CT. Activation of protein C in vivo. J. Clin. Invest. 1982; 70: 127-134
• 8 Hyde E, Wetmore R, Gurewich V. Isolation and characterization of an in vivo thrombin-induced anticoagulant activity. Scand. J. Haemat. 1974; 13: 121-128
• 9 Taylor Jr FB, Chang A, Hinshaw LB, Esmon CT, Archer LT, Beller BK. A model for thrombin protection against endotoxin. Thromb. Res. 1984; 36: 177-185
• 10 Taylor Jr FB, Chang A, Esmon CT, D'Angelo A, Vigano-D'Angelo S, Blick KE. Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon. J. Clin. Invest. 1987; 79: 918-925
• 11 Coalson JJ, Benjamin B, Archer LT, Beller B, Gilliam CL, Taylor FB, Hinshaw LB. Prolonged shock in the baboon subjected to infusion of E. coli endotoxin. Circ. Shock 1978; 5: 423-437
• 12 Reilly CF, Fritze L, Rosenberg RD. Antiproliferative effects of heparin on vascular smooth muscle cells are reversed by epidermal growth factor. J. Cell. Physiol. 1987; 131: 149-157
• 13 Krishnaswamy S, Jones KC, Mann KG. Prothrombinase complex assembly: Kinetic mechanism of enzyme assembly on phospholipid vesicles. J. Biol. Chem. 1988; 263: 3823-3834
• 14 Taylor Jr FB, Chang AK, Mather T, Blick K, Catlett R, Esmon CT. DEGR-Factor Xa blocks disseminated intravascular coagulation initiated by E. coli without preventing shock or organ damage. Blood 1991; in press.
• 15 Warr TA, Rao VM, Rapaport SI. Disseminated intravascular coagulation in rabbits induced by administration of endotoxin or tissue factor: Effect of anti-tissue factor antibodies and measurement of plasma extrinsic pathway inhibitor activity. Blood 1990; 75: 1481-1489
• 16 Walker FJ. Regulation of activated protein C by a new protein. J. Biol. Chem. 1980; 255: 5521-5524
• 17 Comp PC, Nixon RR, Cooper MR, Esmon CT. Familial protein S deficiency is associated with recurrent thrombosis. J. Clin. Invest. 1984; 74: 2082-2088
• 18 Dahlback B. Inhibition of protein Ca cofactor function of human and bovine protein S by C4b-binding protein. J. Biol. Chem. 1986; 261: 12022-12027
• 19 Craddock PR. Complement-mediated intravascular leukostasis and endothelial cell injury. In: Pathobiology of the Endothelial Cell. ( ed. Nossel H. ) Academic Press, Inc., New York,: 1982. pp 369-386
• 20 D'Angelo A, Vigano-D'Angelo S, Esmon CT, Comp PC. Acquired deficiencies of protein S: Protein S activity during oral anticoagulation, in liver disease, and in disseminated intravascular coagulation. J. Clin. Invest. 1988; 81: 1445-1454
• 21 Keeling DM, Campbell SJ, Mackie IJ, Machin SJ, Isenberg DA. Total and free protein S in systemic lupus erythematosus. Thromb. Res. 1990; 60: 237-240
• 22 Beutler B, Milsark IW, Cerami AC. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science 1985; 229: 869-871
• 23 Taylor Jr FB, Esmon CT, Chang A. Primate model of deep vein thrombosis induced by inflammatory mediators.. Circulation 1990; 82 (III) 770 (abstr. #3060)
• 24 Wakefield TW, Wrobleski SK, Sarpa MS, Taylor Jr FB, Esmon CT, Greenfield LJ. Deep venous thrombosis in the baboon generated through protein C inhibition.. (Manuscript submitted)
• 25 Crawford MH, Grover FL, Kolb WP, McMahan A, O'Rourke RA, McManus LM, Pinckard RN. Complement and neutrophil activation in the pathogenesis of ischemic myocardial injury. Circulation 1988; 78: 1449-1458
• 26 Hærem JW. Platelet aggregates in intramyocardial vessels of patients dying suddenly and unexpectedly of coronary artery disease. Atherosclerosis 1972; 15: 199-213
• 27 Maury CPJ, Teppo AM. Circulating tumour necrosis factor (cachectin) in myocardial infarction. J. Int. Med. 1989; 225: 333-336
• 28 Snow TR, Deal MT, Dickey DT, Esmon CT. Protein C activation following coronary artery occlusion in the in-situ porcine heart. Circulation 1991; in press.
• 29 Conway EM, Rosenberg RD. Tumor necrosis factor suppresses transcription of the thrombomodulin gene in endothelial cells. Mol. Cell Biol. 1988; 8: 5588-5592
• 30 Moore K, Esmon CT, Esmon NL. Tumor necrosis factor leads to the internalization and degradation of thrombomodulin from the surface of bovine aortic endothelial cells in culture. Blood 1989; 73: 159-165
• 31 Key NS, Vercellotti GM, Esmon NL, Esmon CT, Jacob HS. Neutrophils enhance the procoagulant effects of tumor necrosis factor on endothelium by accelerating thrombomodulin loss: Role in endotoxin shock.. Clin. Res. 1989; 37: 601A (abstr.)
• 32 Gimbrone Jr MA. Vascular endothelium: Nature's blood container. In: Vascular Endothelium in Hemostasis and Thrombosis, Contemporary Issue in Haemostasis and Thrombosis. ( Gimbrone MA. , ed.) Churchill Livingstone, New York,: 1986. Vol. 2, pp. 01-13